SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN for Immunisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN was used for Immunisation.
Most Reported Side Effects for SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 8 | 40.0% | 0 | 0 |
Other Drugs Used for Immunisation
INFLUENZA VIRUS VACCINE (560)
PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281)
COVID-19 VACCINE NOS (269)
TOZINAMERAN (207)
MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152)
TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148)
PNEUMOCOCCAL VACCINE POLYVALENT (140)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123)
AD26.COV2.S (113)
STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111)